Vaccines & Therapeutic Options
►CDC: Immunization Schedule Changes and Guidelines
►AstraZeneca’s COVID-19 Vaccine Authorised for Emergency Supply in UK
►Merck Announces Supply Agreement with U.S. Gov’t for Initial Doses of Investigational Biological Therapy for Treatment of Patients with Severe and Critical COVID-19
►FDA Takes Additional Action in Fight Against COVID-19; Issues EUA for Second COVID-19 Vaccine
►FDA Authorizes Antigen Test as First Over-the-Counter Fully At-Home Diagnostic Test for COVID-19
►FDA Briefing Document: Moderna COVID-19 Vaccine 12.17 Meeting
►FDA Meeting Announcement: Vaccines & Related Biological Products Advisory Committee December 17, 2020
►FDA Takes Key Action in Fight Against COVID-19 By ...
►FDA Says it ‘Will Rapidly Work Toward’ Authorization of Pfizer-BioNTech Coronavirus Vaccine
►…Know More About mRNA Before Your COVID Jab?
►Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
►Pfizer/BioNTech Vaccine Judged Safe for use in UK From Next Week
►Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study COVID-19 Vaccine Candidate; Filing Today with FDA for EUA
►3rd Major COVID-19 Vaccine Shown to be Effective and Cheaper
►FDA OKs Monoclonal Antibody Cocktail for Less Severe COVID-19
►FDA OKs JAK Inhibitor and Remdesivir Combo for Severe COVID-19
►Pfizer, BioNTech To Seek Emergency COVID-19 Vaccine Nod …
►Pfizer and Biontech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints
►Moderna’s Vaccine Candidate Meets its Primary Efficacy Endpoint …
►Moderna Announces Longer Shelf Life for its COVID-19 Vaccine Candidate at Refrigerated Temperatures
►Pfizer and Biontech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis From Phase 3 Study
►Johnson & Johnson Initiates Second Global Phase 3 Clinical Trial of its Janssen COVID-19 Vaccine Candidate
►Updated: FAQs about COVID-19 Vaccination
►FDA: COVID-19 Vaccines
►HHS: Trump Administration Partners with CVS & Walgreens to Provide COVID-19 Vaccine to Protect Vulnerable Americans in Long-Term Care Facilities Nationwide
►HHS: Trump Administration Takes Action to Further Expand Access to Vaccines, COVID-19 Tests
►NIH: Clinical Trials Site
►Covid-19 Vaccine Trial Participant Had Serious Neurological Symptoms, But . . . , AstraZeneca CEO Says
►Clinical Trials of Monoclonal Antibodies to Prevent COVID-19 Now Enrolling
►Moderna Publishes in The New England Journal of Medicine of Non-Human Primate Preclinical Viral Challenge Study of mRNA Vaccine Against COVID-19 (mRNA-1273)
►COVID-19 Antibody Trials Have Begun
►Monoclonal Antibodies for Prevention and Treatment of COVID-19
►NIH Clinical Trials: Safety/Immunogenicity Study of COVID-19 Vaccine for Prophylaxis of COVID-19 Infection
►Clinical Trials of Monoclonal Antibodies to Prevent COVID-19 Now Enrolling
►Moderna Publishes in The New England Journal of Medicine of Non-Human Primate Preclinical Viral Challenge Study of mRNA Vaccine Against COVID-19 (mRNA-1273)
►COVID-19 Antibody Trials Have Begun
►Monoclonal Antibodies for Prevention and Treatment of COVID-19
